drugset / Trial / NCT05515523
Stromal Vascular Fraction (SVF) for Knee Post-Trauma Osteoarthritis (PTOA)
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective, non-randomized, interventional, dual site, before-after clinical trial to determine feasibility and safety of a single injection of autologous Adipose Derived (AD) Stromal Vascular Fraction (SVF) for the treatment of knee Post Traumatic Osteoarthritis (PTOA).
Timeline
- Start
- 2026-02
- Primary completion
- 2027-11
- Completion
- 2027-11
Outcome
Outcome not reported
Stopped (Business): “Lack of Funding”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adipose Derived (AD) Stromal Vascular Fraction (SVF) | Cell therapy | — | Other |